Changes in the tumor immune microenvironment in resected recurrent soft tissue sarcomas

Abstract

The TIME differs between pre-recurrent STS and post-recurrent STS. The variation in CD8+ T cells and PD-L1 positivity may have essential roles during tumor relapse and provides a basis for determining therapeutic strategies.